Big Pharma with and Uncertain Future - Recensione dipendente - Planning Manager - Sourcing and Supplier Relations presso Merck

3,0
27 apr 2014
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Will provide a paycheck, benefits (although not as good as they used to be), and experience in the industry.

Svantaggi

No direction on where the company is going as a whole or within R&D. There is no personal growth due to financial restrictions in the company. As layoffs continue more work gets shuffled to those who remain and are already overworked. Morale is low.

Esplora altre recensioni su Merck

5,0
3 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

End of the year shutdown which includes paid time off

Svantaggi

The con for me at the time was that I had to relocate which wasn’t possible

4,0
2 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Svantaggi

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Vedi recensioni per: Utile|Valutazione|Data|Tutto